FDA Device Intelligence
HomeRICHARD-ALLAN SCIENTIFIC COMPANY › Epredia

Epredia

RICHARD-ALLAN SCIENTIFIC COMPANY · Model 100% Dehydrant · UDI-DI 00673693476089

PPM
10
510(k) clearances
316
Adverse events (1 deaths)
30
Recalls
259
Facilities

Description

Dehydrant Alcohol product lines are specifically designed for tissue processing and staining of histological and cytological specimens. The products are a clear, colorless blend of ethyl, isopropyl, and methyl alcohol that in some cases have trace amounts of other denatured materials. All Dehydrant Alcohol products are non-controlled substances and do not require record keeping. The formulations are readily miscible with water to form any desired grade of alcohol and can be used with all clearing reagents. The Dehydrant Alcohol line can be used with both open and closed tissue processors. Protective gloves should be worn and work should be performed in a ventilated area. Dehydrant Alcohol is a flammable product and must be stored in a flammable fire cabinet. The Dehydrant Alcohol product line can also be used for hydrating and dehydrating tissue sections during staining. They can be used with all special stains that require dehydration, as solvents for preparing special stains, and immunohistochemical procedures that are compatible with alcoholic dehydrants. The Dehydrant Alcohol product line can be substituted in place of any alcohol you are presently using for hematoxylin and eosin-y staining. They are compatible with all manual procedures and automatic stainers

Recalls

DateFirmReason
2026-03-26Immuno-Mycologics, IncNeutralization Buffer may contain contaminants
2025-11-03GET TESTED INTERNATIONAL ABDistribution without premarket approval/clearance.
2025-10-29Copan ItaliaTreatment reagent functionality in respiratory specimens fluidification cannot be guaranteed.
2025-10-29Copan ItaliaTreatment reagent functionality in respiratory specimens liquification cannot be guaranteed.
2025-05-21Diagnostica Stago, Inc.Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%
2025-04-24Mckesson Medical-Surgical Inc. Corporate Officetransit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failur
2024-09-25Biocare Medical, LLCKits containing the DAB chromogen buffer, intended for use in either manual or automated Immunohistochemistry (IHC) staining protocols, may produce weak to no staining, which may l
2024-05-21Ortho-Clinical Diagnostics, Inc.VITROS Chemistry Products FS Diluent Pack 3, Lot 01-1645 may cause results to be negatively biased when used to dilute patient samples tested with VITROS Chemistry Products CRP Sli
2024-02-07Beckman Coulter, Inc.On 07 February 2024 Beckman Coulter made the decision to conduct a field action on Access Substrate (81906) lots: 234600, 337984, 338040, 338214, 338229, 338289, 338322, 338333, 33
2023-05-24NeuMoDx Molecular IncTop label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.